Which of the following statements about chylomicrons is true?
Which of the following statements is true regarding medium chain fatty acids?
Which of the following is a type of 17 OH steroid?
Which enzyme is primarily responsible for the fat metabolism in adipose tissue?
Apo-E deficiency is seen in which of the following conditions?
In a person fasting overnight with carnitine deficiency, which of the following chemicals increase in quantity in blood?
Which of the following enzymes uses citrate in fatty acid synthesis?
What is the characteristic nitrogenous product of lecithin hydrolysis?
Lipogenesis is stimulated by?
What is the role of Apoprotein C-II in lipid metabolism?
Explanation: ***Chylomicrons primarily contain triglycerides (TGs)*** - **Chylomicrons** are the largest and least dense lipoproteins, primarily responsible for transporting **dietary triglycerides** absorbed from the intestine to peripheral tissues. - They are synthesized in the **enterocytes** of the small intestine and released into the lymphatic system. - Approximately **85-90%** of a chylomicron's mass is composed of **triglycerides**, making them the primary carriers of exogenous fats. *Chylomicrons primarily contain cholesterol* - While chylomicrons do contain some **cholesterol**, it is a minor component (~3-5%) compared to their predominant content, which is **triglycerides**. - Lipoproteins like **LDL** and **HDL** are primarily responsible for cholesterol transport. *Chylomicrons are unrelated to triglyceride transport* - This statement is incorrect; chylomicrons are fundamentally involved in the **transport of dietary triglycerides** from the intestines to various tissues in the body. - After lipoprotein lipase acts on chylomicrons in peripheral tissues, triglycerides are hydrolyzed and fatty acids are taken up by tissues. *Chylomicrons do not primarily contain triglycerides* - This statement directly contradicts the main function and composition of chylomicrons, which are **rich in triglycerides**. - Without triglycerides as their primary content, chylomicrons would not be able to fulfill their physiological role in lipid transport.
Explanation: ***All of the options are true*** - This option is correct because medium-chain fatty acids (MCFAs) possess unique metabolic properties that differentiate them from long-chain fatty acids (LCFAs), making all listed statements accurate. - Their shorter chain length allows for distinct digestion, absorption, and metabolic fates, which are beneficial in various clinical contexts. *Do not require pancreatic lipase for digestion* - MCFAs have **shorter carbon chains** (typically 6-12 carbons) and are more hydrophilic than LCFAs. - This property allows them to be digested by **lingual and gastric lipases** to a greater extent, reducing the reliance on pancreatic lipase. *Absorb directly into portal circulation* - Unlike LCFAs, which are re-esterified into triglycerides, packaged into **chylomicrons**, and absorbed into the lymphatic system, MCFAs are absorbed directly into the **portal vein**. - This bypasses the lymphatic system and directly transports them to the liver, making them a rapid energy source. *Are less likely to be deposited in adipose tissue compared to long-chain fatty acids* - MCFAs are **rapidly oxidized** in the liver for energy via beta-oxidation and are less likely to be stored as triglycerides in adipose tissue. - They are also not efficiently utilized for the synthesis of complex lipids or stored fat due to their unique metabolic pathway and preference for oxidation.
Explanation: ***Cortisol*** - Cortisol is a **glucocorticoid** and is characterized by a **hydroxyl group (-OH)** at the 17th carbon position of its steroid nucleus. - This 17-OH group is crucial for its classification and biological activity as a **17-hydroxycorticosteroid** (17-OH steroid). *Testosterone* - Testosterone is an **androgen** and while it does have a hydroxyl group at the 17β position (making it a 17β-hydroxysteroid), it is NOT classified as a **17-OH steroid (17-hydroxycorticosteroid)**. - The term **"17-OH steroid"** specifically refers to **corticosteroids** with both a hydroxyl at C-17 and a dihydroxyacetone side chain, which testosterone lacks. - Testosterone has a simple hydroxyl at C-17β and lacks the characteristic corticosteroid side chain structure. *Progesterone* - Progesterone is a **progestogen** and lacks a hydroxyl group at the 17th carbon position. - It plays a role in the **menstrual cycle** and **pregnancy** and is primarily characterized by a keto group at C-3 and a two-carbon side chain with a carbonyl group at C-20. *None of the options* - This option is incorrect because **cortisol** is indeed a type of 17-OH steroid (17-hydroxycorticosteroid). - The presence of the 17-hydroxyl group along with the corticosteroid side chain is a defining characteristic of this classification.
Explanation: ***Hormone-sensitive lipase*** - This enzyme is crucial for the **mobilization of stored triglycerides** in adipose tissue by hydrolyzing them into fatty acids and glycerol. - Its activity is stimulated by hormones like **epinephrine** and **norepinephrine** and inhibited by insulin, reflecting its role in regulating fat release during energy demand. *Lipoprotein lipase* - This enzyme is primarily located on the **endothelial surface of capillaries** in various tissues, including adipose tissue, muscle, and heart. - Its main role is to clear **triglyceride-rich lipoproteins** like chylomicrons and VLDL from the bloodstream, facilitating the uptake of fatty acids into cells for storage or energy, rather than direct fat metabolism within the adipose cell. *Acid lipase* - **Lysosomal acid lipase** functions within lysosomes to break down cholesterol esters and triglycerides that are taken up by cells. - Its primary role is in the degradation of lipids within the **lysosomal compartments**, not in the primary process of fat mobilization from adipose tissue stores. *Acid maltase* - Also known as **alpha-glucosidase**, this enzyme is a lysosomal enzyme responsible for breaking down glycogen into glucose. - Its function is related to **glycogen metabolism** and has no direct role in fat metabolism in adipose tissue.
Explanation: ***Type III hyperlipoproteinemia*** - This condition, also known as **familial dysbetalipoproteinemia** or **broad beta disease**, is characterized by a deficiency or abnormal function of **apolipoprotein E (apoE)**. - The deficiency in functional apoE impairs the clearance of **chylomicron remnants** and **intermediate-density lipoproteins (IDLs)** from the blood. *Type II hyperlipoproteinemia* - This condition primarily involves elevated **LDL cholesterol** and is often due to defects in the **LDL receptor** or mutations in **apoB-100**, not apoE deficiency. - It does not directly involve the impaired clearance of chylomicron remnants or IDLs. *Type I hyperlipoproteinemia* - Also known as **familial chylomicronemia syndrome**, this condition is characterized by severe elevation of **chylomicrons** and **triglycerides**. - It is caused by a deficiency of **lipoprotein lipase (LPL)** or its cofactor **apoC-II**, not apoE. *Type IV hyperlipoproteinemia* - This condition, also known as **familial hypertriglyceridemia**, is characterized by abnormally high levels of **very-low-density lipoproteins (VLDL)** and **triglycerides**. - It is typically caused by increased VLDL production or impaired VLDL clearance, but not directly due to an apoE deficiency.
Explanation: ***Fatty acid levels*** - **Carnitine deficiency** impairs the transport of **long-chain fatty acids** into the mitochondria for beta-oxidation. - This leads to an accumulation of **fatty acids** in the blood as they cannot be efficiently metabolized for energy during fasting. - Therefore, **fatty acid levels increase** in the blood. *Ketone body levels* - **Ketone bodies** are produced from the **beta-oxidation of fatty acids** in the liver. - With **carnitine deficiency**, fatty acid oxidation is impaired, thus **reducing** the production of ketone bodies, not increasing them. *Glucose levels* - During **fasting**, the body relies on **gluconeogenesis** and **glycogenolysis** to maintain glucose levels. - With carnitine deficiency primarily affecting fat metabolism and preventing fatty acid utilization, the body cannot spare glucose effectively. - This leads to **hypoglycemia** (decreased glucose), not increased glucose levels. *Amino acid levels* - **Amino acid metabolism** is largely independent of **carnitine**. - While amino acids can be used for gluconeogenesis during fasting, carnitine deficiency does not directly cause an increase in circulating amino acid levels.
Explanation: ***ATP citrate lyase*** - This enzyme is crucial for fatty acid synthesis, as it cleaves **citrate** in the cytoplasm to generate **acetyl-CoA** and oxaloacetate. - The acetyl-CoA produced is then used as the primary building block for **fatty acid synthesis**. *Aconitase* - This enzyme isomerizes **citrate** to isocitrate within the **Krebs cycle** (TCA cycle) in the mitochondria. - It does not directly participate in the cytosolic pathway of fatty acid synthesis. *Citrate synthase* - This enzyme synthesizes **citrate** from acetyl-CoA and oxaloacetate, initiating the **Krebs cycle** in the mitochondrial matrix. - It is involved in citrate formation, not its utilization for fatty acid synthesis in the cytoplasm. *Malic enzyme* - This enzyme converts **malate** to pyruvate, generating **NADPH** in the cytoplasm. - While NADPH is essential for fatty acid synthesis, malic enzyme does not directly use citrate.
Explanation: ***Choline*** - Lecithin is a type of **phospholipid** called **phosphatidylcholine**, meaning its head group contains choline. - Therefore, during hydrolysis, the **choline** component is released as the characteristic nitrogenous product. *Glucose* - **Glucose** is a simple sugar and a carbohydrate, not a component of lecithin. - It is a primary source of **energy** for cells but is not released during lipid hydrolysis. *Fatty acids* - While **fatty acids** are indeed components of lecithin (two fatty acid chains are attached to the glycerol backbone), they are not nitrogenous. - Fatty acids are **hydrophobic hydrocarbon chains** that make up a significant part of the lipid structure. *Phosphoric acid* - **Phosphoric acid** (or phosphate) is also a component of lecithin, connecting the glycerol backbone to the choline group. - However, it is an **inorganic acid** and does not contain nitrogen.
Explanation: ***Insulin*** - **Insulin** is a key anabolic hormone that promotes the synthesis and storage of fat (lipogenesis) by increasing the uptake of glucose into adipose tissue and stimulating enzymes involved in fatty acid synthesis. - It enhances the conversion of excess carbohydrates into **triglycerides** for storage. *Glucagon* - **Glucagon** is a catabolic hormone that primarily promotes the breakdown of glycogen (glycogenolysis) and fat (lipolysis) to release glucose and fatty acids into the bloodstream, especially during fasting. - It generally **inhibits** lipogenesis and stimulates **gluconeogenesis**. *Epinephrine* - **Epinephrine** (adrenaline) is a stress hormone that promotes the breakdown of fat (lipolysis) to provide energy during acute stress or exercise. - It would **inhibit** lipogenesis, as its primary role is to mobilize energy stores. *Corticosteroids* - While **corticosteroids** can influence fat metabolism, their effect on lipogenesis is complex and often indirect. High levels can lead to fat redistribution (e.g., central obesity) rather than direct stimulation of overall lipogenesis. - Corticosteroids generally promote **lipolysis** in the extremities and can contribute to insulin resistance, which would hinder lipogenesis in some tissues.
Explanation: ***Activates lipoprotein lipase*** - **Apoprotein C-II (ApoC-II)** is a crucial **activator** of **lipoprotein lipase (LPL)**. - LPL is an enzyme responsible for **hydrolyzing triglycerides** from chylomicrons and VLDL, allowing fatty acids to be taken up by tissues. - **Deficiency of ApoC-II** leads to severe hypertriglyceridemia due to inability to activate LPL. *Inhibits lipoprotein lipase* - This is the function of **ApoC-III**, not ApoC-II. - ApoC-III **inhibits LPL activity**, which is the opposite role of ApoC-II. *Facilitates triglyceride transport* - While apoproteins are essential for **assembly and transport of lipoproteins** that carry triglycerides, this is not the specific primary role of ApoC-II. - ApoC-II's primary function is **regulating LPL enzyme activity**, not direct transport facilitation. *None of the options* - This is incorrect because ApoC-II clearly **activates lipoprotein lipase**, which is one of the given options.
Lipid Classification and Chemistry
Practice Questions
Fatty Acid Oxidation
Practice Questions
Ketone Body Metabolism
Practice Questions
Fatty Acid Synthesis
Practice Questions
Metabolism of Triacylglycerols
Practice Questions
Phospholipid Metabolism
Practice Questions
Cholesterol Metabolism and Biosynthesis
Practice Questions
Bile Acids and Bile Salts
Practice Questions
Lipoprotein Metabolism and Transport
Practice Questions
Dyslipidemias and Atherosclerosis
Practice Questions
Prostaglandins and Eicosanoids
Practice Questions
Fatty Liver and Lipotropic Factors
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free